PNTG earnings analysis
What we found in PNTG's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The Pennant Group, Inc. reported Q1 2026 results with a total revenue of $285.4 million, surpassing estimates of $280.9 million, but with an EPS of $0.24, falling short of the anticipated $0.29. Despite this earnings miss, the company remains optimistic about growth led by robust performances in home health services and effective acquisition integration.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Exceeds Estimates
- The company reported revenue of $285.4 million, exceeding the estimated $280.9 million for Q1 2026.
- EPS Misses Estimates
- Reported EPS came in at $0.24, below the expected $0.29 for the quarter.
- Growth in Home Health Services
- Management highlighted strong performance in home health services as a key growth driver.
- Solid Revenue Growth Year-over-Year
- Q1 2026 revenue showed significant strength compared to $229 million in Q1 2025, reflecting a 24.6% year-over-year growth.
- Confidence in Operational Integration
- Management noted improvements in integrating acquisitions, contributing to operational efficiencies.
- Strong Performance despite Margin Compression
- Gross margin for the quarter stood at 19.8%, slightly lower than the prior quarter's 19.9%.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Regulatory and Reimbursement Risk
- The company remains exposed to regulatory changes affecting reimbursement, which could impact profitability.
- Integration Challenges with Acquisitions
- Management flagged ongoing integration challenges that could disrupt operational efficiencies in future quarters.
- AI Regulatory Risks
- An additional risk factor has been noted regarding the regulation of artificial intelligence, which may increase compliance costs.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.24
- Gross margin
- 19.8%
What they said about what is next.
No specific numeric guidance was provided; management expressed confidence in growth prospects.
The filing reads about the same as the one before it.
What came before.
- 10-K · February 26, 2026
- The Pennant Group, Inc. reported a strong fiscal year 2025 with a 36.3% increase in revenue, reaching $947.7 million, largely driven by acquisitions and organic growth across its home health and hospice services. The…
- 10-Q · November 5, 2025
- The Pennant Group reported strong Q3 2025 results, with revenues rising 26.8% to $229 million and EPS beating estimates at $0.30 vs. $0.26 expected. Despite this strong performance, the company faces headwinds from…
- 10-Q · August 6, 2025
- The Pennant Group, Inc. reported strong financial results for Q2 2025, with revenues increasing by 30.1% year-over-year to $219.5 million, and EPS rising to $0.27, effectively beating analyst estimates. The company…
- 10-Q · May 6, 2025
- For Q1 2025, Pennant Group reported robust financial performance, generating revenues of $209.8 million, up 33.7% year-over-year, and an EPS of $0.27, exceeding estimates. Despite a notable revenue increase driven by…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing PNTG makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever